The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
J Diabetes. 2021 Dec;13(12):998-1006. doi: 10.1111/1753-0407.13214. Epub 2021 Aug 10.
Poor glycemic control in children with type 1 diabetes (T1D) may hinder sexual development and the associated growth spurt. This study aims to identify factors that may affect the timing of puberty, total pubertal growth (TPG), and final height (F-Ht) in boys with T1D.
This was a retrospective longitudinal study of 68 boys diagnosed with T1D during 1996 to 2009, who were prepubertal at diagnosis and had completed puberty at the time of data collection. Data were accessed regarding anthropometric measurements, Tanner stage, and glycosylated hemoglobin (HbA1c) levels from diagnosis to F-Ht. F-Ht was compared to parental height and Israeli National Health Survey data.
The mean F-Ht standard deviation score (F-Ht-SDS) was lower than the mean Ht-SDS at diagnosis (P < .006) but similar to the mean target height SDS (P = .3) and to values from the national survey (P = .12). Mean HbA1c levels in the year preceding pubertal onset were associated with the age at onset of puberty (R = 0.33, P = .009) and inversely with TPG (R = -0.3, P = .03). Mean HbA1c levels during puberty were inversely associated with TPG (R = -0.26, P = .035) and F-Ht (R = -0.28, P = .02). Boys who presented with diabetic ketoacidosis at diagnosis were shorter than those who did not throughout the follow-up.
We found associations of age of pubertal onset, pubertal growth spurt, and F-Ht with target height and glycemic control before and during puberty. Targeted interventions to achieve optimal metabolic control during these time periods are needed for normal, timely puberty and for achieving optimal adult height within the genetic target height.
1 型糖尿病(T1D)患儿血糖控制不佳可能会阻碍性发育和相关的生长突增。本研究旨在确定可能影响青春期开始时间、总青春期生长(TPG)和 T1D 男孩最终身高(F-Ht)的因素。
这是一项回顾性纵向研究,纳入了 1996 年至 2009 年期间诊断为 T1D 的 68 名男孩,这些男孩在诊断时处于青春期前,且在数据收集时已完成青春期。从诊断到 F-Ht 时,获取了关于身高、Tanner 分期和糖化血红蛋白(HbA1c)水平的相关数据。F-Ht 与父母身高和以色列国家健康调查数据进行了比较。
F-Ht 标准偏差评分(F-Ht-SDS)低于诊断时的 Ht-SDS 平均值(P<0.006),但与目标身高 SDS 平均值相似(P=0.3),与国家调查数据相似(P=0.12)。青春期前一年的平均 HbA1c 水平与青春期开始年龄(R=0.33,P=0.009)和 TPG(R=-0.3,P=0.03)相关。青春期期间的平均 HbA1c 水平与 TPG(R=-0.26,P=0.035)和 F-Ht(R=-0.28,P=0.02)呈负相关。诊断时出现糖尿病酮症酸中毒的男孩在整个随访期间比未出现酮症酸中毒的男孩更矮。
我们发现青春期开始年龄、青春期生长突增和 F-Ht 与目标身高和青春期前后的血糖控制有关。需要针对这些时期进行有针对性的干预,以实现最佳代谢控制,从而实现正常、适时的青春期和在遗传目标身高内达到最佳成人身高。